Case study – BTK inhibitor fenebrutinib Case study – BTK inhibitor fenebrutinib Case study – BTK inhibitor fenebrutinib Oncolines®2021-11-24T08:58:29+01:00
Case study – Arginase-1 Inhibitors Case study – Arginase-1 Inhibitors Case study – Arginase-1 Inhibitors Oncolines®2021-10-21T12:11:18+02:00
Case study – Characterization of TTK Inhibitors Case study – Characterization of TTK Inhibitors Case study – Characterization of TTK Inhibitors Oncolines®2021-10-21T12:11:47+02:00
Case study – BTK Inhibitor ibrutinib Case study – BTK Inhibitor ibrutinib Case study – BTK Inhibitor ibrutinib Oncolines®2021-10-21T12:12:12+02:00
